Good expansion guidance, profitability decent if not for rising labor expenses, revenue was fantastic!
I have been waiting for this pullback. The next 5-10 years you are going to wish you bought at these prices. Easily 5billion plus company.
SHAK topped out above $39 recently and is pulling back. SHAK continues to deliver and should be a huge gainer in 2017.
SHAK climbed nearly 5% in after-hours trading when it was announced that it will replace Chemours in the S&P SmallCap 600 after the close of trading on Wednesday, Jan 4.
SHAK is pulling back after a large rally and continues to deliver, it should be a huge gainer in 2017.